Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03213704
Title Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

pediatric ependymoma

Ewing sarcoma

non-Hodgkin lymphoma

childhood medulloblastoma

sarcoma

Advanced Solid Tumor

neuroblastoma

pediatric osteosarcoma

hepatoblastoma

rhabdomyosarcoma

Therapies

Larotrectinib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.